THIS IS A SOLE / SINGLE SOURCE, NON-COMPETITIVE NOTICE. This notice of intent is not a request for competitive proposals. This sole / single source, non-competitive notice is prepared in accordance FAR Parts 5 and 13. This notice of intent is not a request for competitive proposals. FAR Part 6 – Competition Requirements, is not applicable to contracts awarded using the simplified acquisition procedures of FAR Part 13, not expected to exceed the simplified acquisition threshold. This announcement constitutes the only notice; proposals are not being requested and a written solicitation will not be issued. The resultant acquisition will be conducted in accordance with FAR Part 13, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 2005-34. The total estimated amount of this contract is NOT expected to exceed the simplified acquisition threshold of $100,000.00. The intended procurement will be classified under North American Industry Classification System code 325414 with size standard of 500 employees. Market Research conducted by the Government in accordance with the Federal Acquisition Regulations (FAR) Part 10, Market Research, has determined that the sole / single source reference, is currently the only company that can provide the services / items specified herein. THE NATIONAL INSTITUTES OF HEALTH (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisition (OA) for the National Human Genome Research Institute (NHGRI) intends to negotiate and award a purchase order on a sole source noncompetitive basis to ABCAM, One Kendall SQ, BLDG 200, Cambridge, MA 02139 for the following: 1. Qty 25, Product Number: 1OO~g ab12209, Mouse monoclonal [mAbcam 12209) to Histone H3 (tri methyl K4 2. Qty 15, Product Number: 100~g ab8895, Rabbit polyclonal to Histone H3 (mono methyl K4) - ChIP Grade 3. Qty 25, Product Number: 1OO~g ab9050, Rabbit polyclonal to Histone H3 (tri methyl K36) - ChIP Grade 4. Qty 25, Product Number: 100119 ab3594, Rabbit polyclonal to Histone H3 (di methyl K79) - ChIP Grade 5. Qty 25, Product Number: 100 119 ab6002, Mouse monoclonal [mAbcam 60021 to Histone H3 (tri methyl K27)ChIP Grade 6. Qty 25, Product Number: 100 119 ab1220, Mouse monoclonal [mAbcam 12201to Histone H3 (di methyl K9)ChIP Grade 7. Qty 10, Product Number: 100~1 ab70303, Rabbit polyclonal to CTCF - ChIP Grade 8. Qty 25, Product Number: 100119 ab8898, Rabbit potydonal to Histone H3 (tri methyl K9) - ChIP Grade 9. Qty 25, Product Number: 50111 ab290, Rabbit polyclonal to GFP to x 100119 ab2621 Rabbil polyclonal to Histone H3 (tri methyl K79) - ChIP Grade The sole source determination is based upon the results of the market research conducted by the Government which determined that ABCAM is the only vendor that can supply these antibodies that are needed for the ChIP study used in the Fusion groups laboratory. There are no other companies that can supply the exact same antibodies that would be compatible with the previous conducted ChIP studies. Collaboration has been established for these antibodies under protocol# IZ01HG00024-Genetic analysis of type II diabetes. Therefore, an award to any other source is not feasible or practical. The contract will be awarded using the simplified acquisition procedures of FAR Part 13 - Simplified Acquisition Procedures, therefore the requirements of FAR Part 6 - Competitive Requirements are not applicable (FAR Part 6.001). Interested parties may identify their interest and capability to respond to the requirement or submit a response. This notice of intent is not a request for competitive proposals. Responses to this announcement, referencing synopsis number NHLBI-PB-(HG)-2009-240-TMB may be submitted to the National Heart, Lung and Blood Institute, Office of Acquisitions, Procurement Branch, 6701 Rockledge Drive, Suite 6042, Bethesda, MD 20892-7902, Attention: Tracy Brooks. Responses may be submitted electronically to [email protected]. Responses will only be accepted if dated and signed by an authorized company representative. Responses are due July 22, 2009. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Bid Protests Not Available